Brain fog after COVID-19 shows similar symptomatology and cognitive patterns with Chronic Fatigue Syndrome (CFS), with greater impairment in CFS, reports a study published in the Journal of Translational Medicine.
The objective of this study is to analyze the differences and similarities between CFS/ME and post-COVID-19 condition, focusing especially on the neuropsychological characteristics of both.Patients aged 18–85 years with a sufficient understanding and communication skills, with post-COVID-19 condition and with ME/CFS were recruited from those attending the Neurology Department at Cruces University Hospital.
For patients to be diagnosed with post-COVID-19 condition, any of the following symptoms had to be present at least 3 months after the infection and persisting for at least 2 months []: physical fatigue, mental fatigue, palpitations, sensory symptoms and/or dysautonomic symptoms.
The neuropsychological and neuropsychiatric evaluation was performed in a single day, lasting approximately one hour and a half. To avoid cognitive fatigue, the DSQ was completed by the patients at home.Statistical analyses were carried out using IBM SPSS Statistics for Windows, version 23.0 . For the cognitive variables’ raw data that fulfilled the normality assumption, the Student's t test was carried out to compare the means between groups. In the case of the tests that did not meet this assumption, the U Mann–Whitney test was performed. The raw data of the cognitive test was also transformed into Z scores for each group to create cognitive composites.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
What is the prevalence of COVID-19 detection by PCR among deceased individuals in Lusaka, Zambia? A postmortem surveillance studyObjectives To determine the prevalence of COVID-19 postmortem setting in Lusaka, Zambia. Design A systematic, postmortem prevalence study. Setting A busy, inner-city morgue in Lusaka. Participants We sampled a random subset of all decedents who transited the University Teaching Hospital morgue. We sampled the posterior nasopharynx of decedents using quantitative PCR. Prevalence was weighted to account for age-specific enrolment strategies. Interventions Not applicable—this was an observational study. Primary outcomes Prevalence of COVID-19 detections by PCR. Results were stratified by setting (facility vs community deaths), age, demographics and geography and time. Secondary outcomes Shifts in viral variants; causal inferences based on cycle threshold values and other features; antemortem testing rates. Results From 1118 decedents enrolled between January and June 2021, COVID-19 was detected among 32.0% (358/1116). Roughly four COVID-19+ community deaths occurred for every facility death. Antemortem testing occurred for 52.6% (302/574) of facility deaths but only 1.8% (10/544) of community deaths and overall, only ~10% of COVID-19+ deaths were identified in life. During peak transmission periods, COVID-19 was detected in ~90% of all deaths. We observed three waves of transmission that peaked in July 2020, January 2021 and ~June 2021: the AE.1 lineage and the Beta and Delta variants, respectively. PCR signals were strongest among those whose deaths were deemed ‘probably due to COVID-19’, and weakest among children, with an age-dependent increase in PCR signal intensity. Conclusions COVID-19 was common among deceased individuals in Lusaka. Antemortem testing was rarely done, and almost never for community deaths. Suspicion that COVID-19 was the cause of deaths was highest for those with a respiratory syndrome and lowest for individuals |19 years. Data are available upon reasonable request.
Read more »
Lancashire school closures today as snow, ice and Covid takes tollParklands High School in Chorley is fully closed while Bleasdale School in Carnforth is partially shut
Read more »
Zero to sickly? China’s covid climbdownWith astonishing speed, the machinery of testing, tracing and lockdowns is being dismantled. We examine the risks that will pose to a country that is not prepared for big outbreaks. A winemaker’s lawsuit in Napa Valley reveals why many Californians believe regulators are unfriendly to business. And a clever solution to spare sharks from becoming unwanted “bycatch”. Help us make the show better: take our listener survey at http://economist.com/intelligencesurvey For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/intelligenceoffer Hosted on Acast. See acast.com/privacy for more information.
Read more »
Nasal COVID-19 vaccine approved for use as booster in IndiaA nasal COVID-19 vaccine based on technology licensed from Washington University in St. Louis has been approved for emergency use in India as a booster for people who have already received two doses of other COVID-19 vaccines. The approval follows the Indian government's emergency use authorization in September of the vaccine as a primary series of two doses, and makes the intranasal vaccine the world's first to receive approval as both a primary vaccine for COVID-19 and a booster.
Read more »
Hospitalizations Signal Rising COVID Risk for U.S. SeniorsCoronavirus-related hospital admissions are climbing again in the U.S., with older adults a growing share of U.S. deaths and less than half of nursing home residents up to date on COVID-19 vaccinations
Read more »
Notts firm enters administration with nearly 30 jobs lostThe company has been affected by the Covid pandemic and Ukraine war
Read more »